Company
United StatesShilpa Gupta, Minneapolis, MN – FDA Inspections
Inspection records and compliance data for Shilpa Gupta in Minneapolis, Minnesota. 2 FDA inspections on record, last inspected March 20, 2026.
Company Profile
This profile covers Shilpa Gupta based in Minneapolis, Minnesota, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected July 20, 2017. Last inspected March 20, 2026.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 20, 2026 | Not classified | Human Drugs | 1310244 |
| July 20, 2017 | NAI | Human Drugs · Bioresearch Monitoring | 1021703 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Shilpa Gupta
FEI Number
3013353873
Address
925 Delaware St Se, Ste 300, Minneapolis, Minnesota 55414, United States
Country
United States
ID: 393d9806-25b2-4496-a48b-a6cf2804764d